Showing results (1-10 of 360) with videos related to
Sort By:
Pageof 36
Expert Review of Molecular Diagnostics|September 26, 2007
Progensa PCA3 test for prostate cancer detectionAlexandre de la TailleUrology Practice|August 4, 2023
Does PCA3 Really Help Urologists?Guillaume Ploussard, Alexandre de la TailleExpert Review of Anticancer Therapy|July 19, 2018
The role of prostate cancer antigen 3 (PCA3) in prostate cancer detectionGuillaume Ploussard, Alexandre de la TailleProgres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 8, 2005
[Adjuvant chemotherapy and/or hormone therapy after radical prostatectomy for high-risk prostate cancer]Bernard Paule, Alexandre de la TailleNature Reviews. Urology|January 13, 2010
Urine biomarkers in prostate cancerGuillaume Ploussard, Alexandre de la TailleCurrent Opinion in Urology|November 4, 2010
Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?Grégoire Robert, Aurélien Descazeaud, Alexandre de la TailleWorld Journal of Urology|August 28, 2014
Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trialsGrégoire Robert, Alexandre de la Taille, Thomas HerrmannPathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 17, 2011
Kidney cancer pathology in the new context of targeted therapyYves Allory, Stéphane Culine, Alexandre de la TailleCurrent Urology Reports|February 9, 2012
Radical prostatectomy as primary treatment of high-risk prostate cancerAlexandre Ingels, Alexandre de la Taille, Guillaume PloussardBJU International|March 16, 2006
The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasiaFrançois Desgrandchamps, Alexandre De La Taille, Jean-Dominique Doublet, et al.Pageof 36